Tag: Numinus - Page 8 - Psychedelic Alpha

Numinus Upgrades Psychedelics Lab to Increase Research Service Capabilities

Post published:October 8, 2021
Post category:Press Release

Read more about the article Numinus Completes Acquisition of Neurology Centre of Toronto

Numinus Completes Acquisition of Neurology Centre of Toronto

Post published:September 23, 2021
Post category:Press Release

Numinus Wellness Closes Q3 2021 With $63.2 Million Cash Position, Lab and Trial Advances, and Strategic Expansion into Psychedelic Neurology

Post published:July 29, 2021
Post category:Press Release

Numinus Announces Health Canada Approval of MAPS-Sponsored Open Label Study for MDMA-Assisted Therapy for PTSD

Post published:July 12, 2021
Post category:Press Release

Numinus Wellness To Acquire Neurology Centre of Toronto, Plans to Create Centre for Psychedelic Neurology

Post published:July 6, 2021
Post category:Press Release

Numinus Files U.S. Provisional Patent Application for a Proprietary Rapid Production Process for Psilocybe and Other Psychoactive Fungi Species

Post published:June 24, 2021
Post category:Press Release

Numinus Wellness Graduates to Tier 1 on the TSX Venture Exchange

Post published:June 18, 2021
Post category:Press Release

Read more about the article Numinus Wellness Announces Key Leadership Hires to Support Rapid Growth and Innovation

Numinus Wellness Announces Key Leadership Hires to Support Rapid Growth and Innovation

Post published:May 13, 2021
Post category:Press Release

Numinus Wellness and Optimi Health Submit All-Natural Psilocybin Extract to Health Canada for Pre-Clinical Trial Application

Post published:May 11, 2021
Post category:Press Release

Numinus Congratulates MAPS on Phase 3 Clinical Trial Demonstrating Significant Benefits of MDMA-Assisted Therapy for Severe PTSD

Post published:May 10, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.